Sampling-time Error Induced Concentration Bias of Tacrolimus Monitoring in Pediatric Patients with Nephrotic Syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022724

Enrollment

Unknown

Registered

2019-04-23

Start date

2019-05-01

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic Syndrome

Interventions

children with nephrotic syndrome who treated with tacrolimus: scheduled for therapeutic drug monitoring

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with nephrotic syndrome; 2. Age <18 years old; 3. Patients who received the same dose of tacrolimus for at least 3 consecutive days and were scheduled for therapeutic drug monitoring the following day.

Exclusion criteria

Exclusion criteria: Patients who did not sign the informed consent of this study

Design outcomes

Primary

Measure	Time frame
sampling-time error induced concentration bias;	—

Countries

China

Contacts

Public ContactLuo Fang

Children's Hospital, Zhejiang University School of Medicine

fangluo@zju.edu.cn+86 571 86670401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026